Citation Impact
Citing Papers
Phase II Study of Celecoxib and Trastuzumab in Metastatic Breast Cancer Patients Who Have Progressed after Prior Trastuzumab-Based Treatments
2004
Glutathione S-transferase M1 and T1 genetic polymorphisms, alcohol consumption and breast cancer risk
2003
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Inflammation and Alzheimer's disease
2000 Standout
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
2009 Standout
Cyclooxygenase-2: a potential target in breast cancer
2004
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Management of cancer pain
1999 Standout
Cancer chemoprevention with dietary phytochemicals
2003 Standout
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
The role of COX-2 inhibition in breast cancer treatment and prevention
2004
Signal integration by JNK and p38 MAPK pathways in cancer development
2009 Standout
Exploring the Relation of Alcohol Consumption to Risk of Breast Cancer
2001
Human Genetics Shape the Gut Microbiome
2014 Standout
Resveratrol Inhibits Cyclooxygenase‐2 Transcription in Human Mammary Epithelial Cells
1999
Ceramide Regulates the Transcription of Cyclooxygenase-2
1998
Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical Issues
2002
Endometriosis
2009 Standout
Expression of Angiogenesis-Related Genes and Progression of Human Ovarian Carcinomas in Nude Mice
1998
Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy
1999
Enhancement of carcinogen-induced malignant cell transformation by prostaglandin F2α
2003
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
2005 Standout
Cyclooxygenases in reproductive medicine and biology
1999
Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP1 antagonist, on breast cancer development
2001
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Alcohol and public health
2005 Standout
Maternal and child undernutrition: consequences for adult health and human capital
2008 Standout
COX-2 Inhibitors and Their Role in Gynecology
2002
Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer
2002
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
2010 Standout
Obesity
2005 Standout
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Neoplasms escape selective COX-2 inhibition in an animal model of breast cancer
2009
Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
2009 Standout
Inhibition of Cyclooxygenase-2 Gene Expression by p53
1999
Body Mass Index and Breast Cancer Risk According to Postmenopausal Estrogen-Progestin Use and Hormone Receptor Status
2013
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
2010 Standout
Resveratrol Inhibits Cyclooxygenase-2 Transcription and Activity in Phorbol Ester-treated Human Mammary Epithelial Cells
1998 Standout
Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?
2003
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer
2006
Obesity and cancer risk: a danish record-linkage study
1994
Eicosanoids and cancer
2010 Standout
Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer
2002
Paradoxical roles of the immune system during cancer development
2006 Standout
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
2004 StandoutNature
How does calorie restriction work?
2003
Catch-up growth and obesity in male mice
2004 Nature
Actual Causes of Death in the United States, 2000
2004 Standout
Periodontal diseases
2005 Standout
Understanding breast cancer risk - where do we stand in 2005?
2005
Exposures in Childhood, Adolescence and Early Adulthood and Breast Cancer Risk: a Systematic Review of the Literature
2003
Epidemiology of breast cancer: Findings from the nurses' health study
1993
Cardiac remodeling and diastolic dysfunction in DahlS.Z-Leprfa/Leprfa rats: a new animal model of metabolic syndrome
2011
The Preventable Causes of Death in the United States: Comparative Risk Assessment of Dietary, Lifestyle, and Metabolic Risk Factors
2009 Standout
Expression of Cyclooxygenase-1 and Cyclooxygenase-2 in Human Breast Cancer
1998
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
2010 Standout
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Sirtuin activators mimic caloric restriction and delay ageing in metazoans
2004 StandoutNature
Hepatocellular Carcinoma
2011 Standout
Role of Cyclooxygenase-2 in Breast Cancer
2002
Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung
2009
Tumorigenesis and the angiogenic switch
2003 Standout
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
2003 Standout
Resveratrol Suppresses TNF-Induced Activation of Nuclear Transcription Factors NF-κB, Activator Protein-1, and Apoptosis: Potential Role of Reactive Oxygen Intermediates and Lipid Peroxidation
2000 Standout
Breast cancer and hormone-replacement therapy in the Million Women Study
2003 Standout
Cyclooxygenases: Structural, Cellular, and Molecular Biology
2000 Standout
Nature, Nurture, and Twin Research Strategies
1997
Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation.
1999
Endocrine and Paracrine Regulation of Birth at Term and Preterm*
2000 Standout
The quantification of drug-caused mortality and morbidity in Australia, 1998
2001
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells.
1999
Preparation of Porous Polysaccharides Templated by Coordination Polymer with Three-Dimensional Nanochannels
2017 StandoutNobel
A Twin Study of Genetic Variation in Proportional Radiographic Alveolar Bone Height
1991
Transcriptional control of human p53-regulated genes
2008 Standout
Effects of Energy Balance on Cancer in Genetically Altered Mice
2004
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
CYCLOOXYGENASES 1 AND 2
1998 StandoutNobel
Cyclooxygenase-2 Inhibitor Induces Apoptosis in Breast Cancer Cells in an In vivo Model of Spontaneous Metastatic Breast Cancer
2004
Subjective well-being: Three decades of progress.
1999 Standout
Enhancing Radiotherapy With Cyclooxygenase-2 Enzyme Inhibitors: A Rational Advance?
2003
The Study of Human Twins in Medical Research
1984
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 Standout
A Population-Based Study of Multiple Sclerosis in Twins
1986 Standout
Interactions between Prostaglandin E2, Liver Receptor Homologue-1, and Aromatase in Breast Cancer
2005
Model-fitting approaches to the analysis of human behaviour
1978
Expression of cyclooxygenase-2 in human lung carcinoma.
1998
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Suppression of tumour development by substances derived from the diet—mechanisms and clinical implications
1998
Works of RE Harris being referenced
Breast Cancer Risk: Effects of Estrogen Replacement Therapy and Body Mass
1992
Chemotherapeutic evaluation of Celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model.
2000
Effects of chorion type on variation in cord blood cholesterol of monozygotic twins.
1976
Does alcohol consumption influence the risk of developing breast cancer? Two views.
1989
Cyclooxygenase-2 gene expression in human breast cancer
1997
Longevity in obese and lean male and female rats of the Zucker strain: prevention of hyperphagia
1997